Generex Biotechnology extends scope of U.S. patent protection for vaccine technology
Advertisement
Generex Biotechnology Corporation announced that that its wholly owned subsidiary, Antigen Express, Inc., has received a Notice of Allowance in connection with US Patent Application No. 10/197,000 entitled Hybrid peptides Modulate the Immune Response. The specific award covers fundamental aspects of the design and use of Ii-Key antigenic epitope hybrids in treating disease.
According to the company, potentiation of the therapeutic and prophylactic potency of vaccines using Ii-Key hybrids is a core component of Antigen Express technology. Ii-Key is a small fragment of the MHC class II associated invariant chain (Ii protein) that works by increasing the ability of specific antigens to stimulate T helper cells. Antigen Express has recently initiated a Phase II clinical trial designed to test the efficacy of one of its immunotherapeutic Ii-Key hybrid vaccines (AE37) in breast cancer. It has also initiated clinical trials on a synthetic avian influenza vaccine designed using the same principal.
Most read news
Topics
Organizations
Other news from the department research and development
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Acacia Pharma raises £15 million to advance clinical development of lead products for supportive care
Pronova BioPharma appoints Per-Oluf Olsen as new CEO
Mucosis Receives Financial Support from the Dutch Government for Its Flugem Program
Researchers find way to kill pathogen resistant to antibiotics
VTT has developed a rapid image analysis method to help diagnose Alzheimer's disease
A lab in your pocket
How brain areas communicate shapes human communication - The hearing regions in your brain form new alliances as you try to listen at the cocktail party